Integrated Diagnostics Holdings plc (IDGXF)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.77 Billion EGP | 8.95% |
| 2022 | 5.29 Billion EGP | -15.07% |
| 2021 | 6.23 Billion EGP | 49.28% |
| 2020 | 4.17 Billion EGP | 11.24% |
| 2019 | 3.75 Billion EGP | 9.37% |
| 2018 | 3.43 Billion EGP | 10.35% |
| 2017 | 3.11 Billion EGP | 2.17% |
| 2016 | 3.04 Billion EGP | 22.65% |
| 2015 | 2.48 Billion EGP | 11.1% |
| 2014 | 2.23 Billion EGP | -2.14% |
| 2013 | 2.28 Billion EGP | -6.51% |
| 2012 | 2.44 Billion EGP | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 6.76 Billion EGP | 4.33% |
| 2024 Q1 | 6.48 Billion EGP | 12.44% |
| 2023 Q4 | 5.77 Billion EGP | 0.71% |
| 2023 Q1 | 5.56 Billion EGP | 5.12% |
| 2023 FY | 5.77 Billion EGP | 8.95% |
| 2023 Q2 | 5.47 Billion EGP | -1.74% |
| 2023 Q3 | 5.72 Billion EGP | 4.73% |
| 2022 Q2 | 6.29 Billion EGP | -6.32% |
| 2022 Q4 | 5.29 Billion EGP | 6.28% |
| 2022 Q3 | 4.98 Billion EGP | -20.85% |
| 2022 FY | 5.29 Billion EGP | -15.07% |
| 2022 Q1 | 6.72 Billion EGP | 7.76% |
| 2021 Q4 | 6.23 Billion EGP | 11.74% |
| 2021 Q3 | 5.58 Billion EGP | 8.69% |
| 2021 FY | 6.23 Billion EGP | 49.28% |
| 2021 Q2 | 5.13 Billion EGP | 0.0% |
| 2020 Q1 | - EGP | -100.0% |
| 2020 Q4 | 4.17 Billion EGP | 0.0% |
| 2020 Q2 | 3.83 Billion EGP | 0.0% |
| 2020 FY | 4.17 Billion EGP | 11.24% |
| 2019 Q2 | 3.37 Billion EGP | 0.0% |
| 2019 FY | 3.75 Billion EGP | 9.37% |
| 2019 Q4 | 3.75 Billion EGP | 0.0% |
| 2019 Q1 | - EGP | -100.0% |
| 2018 Q3 | - EGP | -100.0% |
| 2018 Q4 | 3.43 Billion EGP | 0.0% |
| 2018 FY | 3.43 Billion EGP | 10.35% |
| 2018 Q1 | 2.91 Billion EGP | -6.36% |
| 2018 Q2 | 2.91 Billion EGP | 0.0% |
| 2017 Q4 | 3.11 Billion EGP | 0.0% |
| 2017 Q1 | 2.83 Billion EGP | -7.01% |
| 2017 Q2 | 2.83 Billion EGP | 0.0% |
| 2017 FY | 3.11 Billion EGP | 2.17% |
| 2016 Q1 | 2.52 Billion EGP | 1.51% |
| 2016 FY | 3.04 Billion EGP | 22.65% |
| 2016 Q2 | 2.52 Billion EGP | 0.0% |
| 2016 Q4 | 3.04 Billion EGP | 0.0% |
| 2016 Q3 | - EGP | -100.0% |
| 2015 Q1 | 2.31 Billion EGP | 3.42% |
| 2015 FY | 2.48 Billion EGP | 11.1% |
| 2015 Q4 | 2.48 Billion EGP | 0.0% |
| 2015 Q2 | 2.31 Billion EGP | 0.0% |
| 2014 Q4 | 2.23 Billion EGP | 0.0% |
| 2014 Q1 | - EGP | -100.0% |
| 2014 FY | 2.23 Billion EGP | -2.14% |
| 2013 Q4 | 2.28 Billion EGP | 0.0% |
| 2013 FY | 2.28 Billion EGP | -6.51% |
| 2012 FY | 2.44 Billion EGP | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -454614.421% |
| Arrayit Corporation | 1 Million USD | -576708.222% |
| Atlantic International Corp. | 4.43 Million USD | -129968.901% |
| Biocept, Inc. | 30.87 Million USD | -18590.526% |
| Bioqual, Inc. | 56.58 Million USD | -10097.106% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -2487838.706% |
| DermTech, Inc. | 121.93 Million USD | -4632.491% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | -37.882% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | -32358.308% |
| iMD Companies, Inc. | 190.13 Thousand USD | -3034725.415% |
| IDenta Corp. | 1.52 Million USD | -377224.288% |
| Interpace Biosciences, Inc. | 13.02 Million USD | -44215.536% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -69827.131% |
| InVitro International | 1.53 Million USD | -376060.343% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | -21400.581% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -249581474.394% |
| Medical Imaging Corp. | 4.19 Million USD | -137563.156% |
| NovelStem International Corp. | 2.25 Million USD | -255841.817% |
| Optigenex Inc. | 1.88 Million USD | -305484.735% |
| PharmChem, Inc. | 2.76 Million USD | -208549.535% |
| Proteome Sciences plc | 14.58 Million USD | -39460.626% |
| Response Genetics, Inc | 48.88 Million USD | -11704.12% |
| Rennova Health, Inc. | 20.57 Million USD | -27948.378% |
| RushNet, Inc. | 6.04 Million USD | -95315.093% |
| ScreenPro Security Inc. | 1.26 Million USD | -457368.968% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -1221332.064% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -823465.194% |
| Todos Medical Ltd. | 15.26 Million USD | -37696.07% |